ALTRABIO SAS

AltraBio is a R&D company specializing in the analysis and interpretation of preclinical and clinical biomedical data. Particularly focused on "OMICS" technologies (genomics, transcriptomics, proteomics, etc.) and cytometry, AltraBio's mission is to optimize the value of results obtained from high-throughput experimental studies in life sciences and to accelerate your R&D data analysis and clinical trial processes for the discovery of new molecules, diagnostics, and the optimization of population identification processes. In the field of cytometry, AltraBio offers to reproduce and standardize your gating strategy across all files of your study through a unique, internally developed service. This approach, based on machine learning, frees the experimenter from this tedious and time-consuming task and has numerous advantages, especially in clinical trials: Standardization of gating strategy application, Increased reliability (reproducibility and accuracy), Elimination of subjectivity/variability associated with manual gating, Reduction of analysis time.